PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Sues Eli Lilly Over Obesity Drug Advertisements

Danish manufacturer Novo Nordisk announced it is seeking a provisional injunction from a US court to immediately block advertisements for obesity and diabetes drugs by American company Eli Lilly. The lawsuit involves popular medications like Wegovy, Ozempic, Mounjaro, and Zepbound.

24 Jul, 17:20 — 24 Jul, 17:20
PostShare

Sources

Showing 1 of 2 sources
YahooMostly Factual13h ago

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors?

Read full article →

Coverage Timeline

First report: hotnews · 24 Jul, 11:40Full coverage: 2 · 6hWindow: 6h
Left-leaningCenterRight-leaning
hotnews24 Jul, 11:40First to report

Producătorii unor populare medicamente pentru slăbit, război în instanță. De la ce a pornit râca dintre companiile care fac Wegovy, Ozempic, Mounjaro și Zepbound

6h later
Yahoo24 Jul, 17:20Latest update

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors?

Related Stories

Oldest Known Plague Outbreak Discovered in Siberia Dating Back 5,500 Years

just now

Nutritionist Evaluates Healthy Lunchbox Options

22m ago

Nigeria's Lassa Fever Death Toll Reaches 229 Amid Rising Infections

28m ago

Twenty Years of Evidence: What ISPUP Has Done for Portuguese Health

58m ago